| Antibody (ELISA, IgG) |
East-Asia and Pacific |
2 |
47% |
40% |
55% |
52% |
49% |
55% |
| Antibody (ELISA, IgM) |
East-Asia and Pacific |
2 |
63% |
57% |
69% |
76% |
74% |
79% |
| Antibody (Lateral flow, IgM) |
East-Asia and Pacific |
1 |
55% |
39% |
70% |
98% |
96% |
99% |
| Antigen (Rapid diagnostic test (RDT)) |
East-Asia and Pacific |
1 |
91% |
59% |
100% |
96% |
81% |
100% |
| Antigen (TUBEX TP, O12) |
East-Asia and Pacific |
1 |
100% |
88% |
100% |
100% |
93% |
100% |
| PCR/DNA |
East-Asia and Pacific |
1 |
41% |
26% |
57% |
100% |
99% |
100% |
| Antibody (ELISA, IgA) |
South Asia |
2 |
91% |
79% |
98% |
79% |
70% |
86% |
| Antibody (ELISA, IgG or IgM) |
South Asia |
1 |
74% |
56% |
87% |
80% |
74% |
85% |
| Antibody (ELISA, IgG) |
South Asia |
2 |
59% |
45% |
72% |
71% |
65% |
77% |
| Antibody (ELISA, IgM) |
South Asia |
2 |
75% |
62% |
86% |
78% |
72% |
83% |
| Antibody (Enterocheck WB, IgM) |
South Asia |
1 |
85% |
73% |
94% |
89% |
85% |
92% |
| Antibody (Lateral flow, IgG) |
South Asia |
1 |
98% |
90% |
100% |
78% |
68% |
86% |
| Antibody (Lateral flow, IgM or IgG) |
South Asia |
1 |
69% |
57% |
79% |
71% |
65% |
77% |
| Antibody (TPT test, S. Typhi specific IgA) |
South Asia |
2 |
100% |
94% |
100% |
69% |
62% |
75% |
| Antibody (TUBEX, IgM) |
South Asia |
4 |
63% |
55% |
71% |
84% |
81% |
88% |
| Antibody (Typhidot, IgG) |
South Asia |
2 |
13% |
4% |
30% |
33% |
26% |
41% |
| Antibody (Typhidot, IgM or IgG) |
South Asia |
1 |
65% |
44% |
83% |
66% |
50% |
80% |
| Antibody (Typhidot, IgM) |
South Asia |
6 |
77% |
70% |
83% |
60% |
56% |
65% |
| Antigen (Reverse Passive Hemagluttination) |
South Asia |
1 |
100% |
93% |
100% |
76% |
66% |
84% |
| Diazo |
South Asia |
1 |
87% |
69% |
96% |
86% |
77% |
93% |
| nested PCR (blood) |
South Asia |
3 |
45% |
34% |
55% |
83% |
78% |
88% |
| PCR/DNA |
South Asia |
2 |
48% |
27% |
69% |
84% |
77% |
90% |
| Widal (H) 1:160 (H) |
South Asia |
1 |
30% |
15% |
49% |
98% |
89% |
100% |
| Widal (H) 1:200 (H), 1:100 (O) |
South Asia |
1 |
30% |
15% |
49% |
91% |
83% |
96% |
| Widal (O or H) 1:80 (O or H) |
South Asia |
1 |
92% |
75% |
99% |
100% |
29% |
100% |
| Widal (O) 1:160 (O) |
South Asia |
1 |
70% |
51% |
85% |
94% |
83% |
99% |
| Widal (O) 1:180 (O) |
South Asia |
1 |
63% |
51% |
73% |
37% |
31% |
43% |
| Widal (O) 1:80 (O) |
South Asia |
2 |
57% |
49% |
65% |
74% |
66% |
80% |
| Widal slide (H) 1:160 (H) |
South Asia |
1 |
86% |
79% |
91% |
98% |
93% |
100% |
| Widal slide (O or H) 1:160 (O or H) |
South Asia |
3 |
74% |
65% |
81% |
68% |
62% |
74% |
| Widal slide (O) 1:80 (O) |
South Asia |
1 |
71% |
63% |
78% |
98% |
93% |
100% |
| Antibody (ELISA, total Ig) |
Sub-Saharan Africa |
1 |
87% |
74% |
95% |
75% |
48% |
93% |
| Antibody (TUBEX, IgM) |
Sub-Saharan Africa |
1 |
79% |
61% |
91% |
89% |
81% |
94% |
| PCR/DNA |
Sub-Saharan Africa |
1 |
88% |
64% |
99% |
86% |
80% |
90% |
| Widal (H) 1:80 (H) |
Sub-Saharan Africa |
1 |
75% |
48% |
93% |
95% |
91% |
98% |
| Widal (O) 1:80 (O) |
Sub-Saharan Africa |
1 |
69% |
41% |
89% |
96% |
91% |
98% |
